Literature DB >> 23244171

Surfactant protein D as a biomarker for chronic obstructive pulmonary disease.

Russell P Bowler1.   

Abstract

Clinical research in chronic obstructive pulmonary disease (COPD) has been hampered by the lack of validated blood biomarkers. The ideal COPD biomarker would have the following characteristics: (1) it would be a lung specific protein that could be assayed in blood; (2) it would change with disease severity or during exacerbations; (3) it would be specific for COPD; and would be responsive to change with effective treatments. One such candidate is the lung specific protein surfactant protein D (SP-D). In this review, we discuss the evidence supporting SP-D as a COPD biomarker.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23244171     DOI： 10.3109/15412555.2012.736317

Source DB:  PubMed          Journal:  COPD        ISSN： 1541-2563            Impact factor:   2.409


  9 in total

1.  Serum pneumoproteins in tunnel construction workers.

Authors:  Dag G Ellingsen; Bente Ulvestad; Berit Bakke; Ingebjørg Seljeflot; Lars Barregard; Yngvar Thomassen
Journal:  Int Arch Occup Environ Health       Date:  2015-01-30       Impact factor: 3.015

2.  microRNA-183 down-regulates the expression of BKCaβ1 protein that is related to the severity of chronic obstructive pulmonary disease.

Authors:  Z Cao; N Zhang; T Lou; Y Jin; Y Wu; Z Ye; J Pan
Journal:  Hippokratia       Date:  2014 Oct-Dec       Impact factor: 0.471

Review 3.  The molecular era of surfactant biology.

Authors:  Jeffrey A Whitsett
Journal:  Neonatology       Date:  2014-05-30       Impact factor: 4.035

4.  Integrative analysis of DNA methylation and gene expression data identifies EPAS1 as a key regulator of COPD.

Authors:  Seungyeul Yoo; Sachiko Takikawa; Patrick Geraghty; Carmen Argmann; Joshua Campbell; Luan Lin; Tao Huang; Zhidong Tu; Robert F Foronjy; Robert Feronjy; Avrum Spira; Eric E Schadt; Charles A Powell; Jun Zhu
Journal:  PLoS Genet       Date:  2015-01-08       Impact factor: 5.917

5.  Clinical significance of nuclear factor erythroid 2-related factor 2 in patients with chronic obstructive pulmonary disease.

Authors:  Woo Ho Ban; Hyeon Hui Kang; In Kyoung Kim; Jick Hwan Ha; Hyonsoo Joo; Jong Min Lee; Jeong Uk Lim; Sang Haak Lee; Chin Kook Rhee
Journal:  Korean J Intern Med       Date:  2018-03-13       Impact factor: 2.884

6.  Pneumoproteins in Offshore Drill Floor Workers.

Authors:  Niels E Kirkhus; Bente Ulvestad; Lars Barregard; Øivind Skare; Raymond Olsen; Yngvar Thomassen; Dag G Ellingsen
Journal:  Int J Environ Res Public Health       Date:  2019-01-23       Impact factor: 3.390

7.  The role of serum surfactant protein D as a biomarker of exacerbation of chronic obstructive pulmonary disease.

Authors:  Alaa Zien Alaabden; Yousser Mohammad; Sahar Fahoum
Journal:  Qatar Med J       Date:  2016-01-26

8.  Serum Metabolite Biomarkers Discriminate Healthy Smokers from COPD Smokers.

Authors:  Qiuying Chen; Ruba S Deeb; Yuliang Ma; Michelle R Staudt; Ronald G Crystal; Steven S Gross
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

9.  Effects of Bufei Yishen Granules Combined with Acupoint Sticking Therapy on Pulmonary Surfactant Proteins in Chronic Obstructive Pulmonary Disease Rats.

Authors:  Yange Tian; Jiansheng Li; Ya Li; Yuqiong Dong; Fengjia Yao; Jing Mao; Linlin Li; Lili Wang; Shan Luo; Minghang Wang
Journal:  Biomed Res Int       Date:  2016-09-06       Impact factor: 3.411
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.